GoingToMeet

The New Developments in Lung and Head & Neck Cancers regional symposia are designed to update practicing oncologists and thoracic surgeons on recent advances in the management of lung and head & neck cancers, particularly those advances reported at major oncology meetings in 2008. Recent developments in the use of targeted agents, including anti-EGFR and antiangiogenic agents, in the treatment of NSCLC will be discussed. Additionally, efforts to individualize treatment according to histology and pharmacogenomics will be addressed. An overview of efforts to optimize chemotherapy for lung cancer will also be presented. In head and neck cancer, new approaches to improve systemic therapy through the use of predictive markers, targeted agents, and induction regimens will be discussed. Case-based discussions will be held, and there will be ample time for interaction with the faculty.